Calcitonin Gene-Related Peptide Monoclonal Antibody Treatments for Migraine

@article{Loder2019CalcitoninGP,
  title={Calcitonin Gene-Related Peptide Monoclonal Antibody Treatments for Migraine},
  author={E. Loder and William Renthal},
  journal={JAMA Internal Medicine},
  year={2019},
  volume={179},
  pages={421–422}
}
Background Migraine is a disabling condition determined by both genetic and environmental factors. It affects an estimated 32 million people in the United States2 and produces a lifelong predisposition to develop severe headache and associated symptoms spontaneously or in response to triggers. Occasional migraine attacks usually are treated individually with symptomatic medications such as triptans. If attacks are frequent, regularly administered preventive treatment may decrease headache… Expand
3 Citations

Topics from this paper

References

SHOWING 1-6 OF 6 REFERENCES
New preventive treatments for migraine
  • 10
The prevalence and impact of migraine and severe headache in the united states: figures and trends from government health studies. Headache
  • 2018
The prevalence and impact of migraine and severe
  • headache